On December 28, 2022 Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, reported that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, will participate at the upcoming Biotech Showcase 2023 Conference on Tuesday, January 10th, 2023, at 10:00 a.m. PST in San Francisco, CA (Press release, Aptose Biosciences, DEC 28, 2022, View Source [SID1234625636]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Presentation Details:

Date: Tuesday, January 10, 2023
Time: 10:00 a.m. PST
Location: Track Yosemite – C (Ballroom Level)
Hilton San Francisco Union Square, 333 O’Farrell Street, San Francisco, CA 94102
Webcast: LINK
The audio webcast will be archived shortly after the live event and will be available through the Aptose website, www.aptose.com.

The Company also will be hosting institutional investor and partnering meetings at the LifeSci Advisors Corporate Access Event taking place in San Francisco on January 9-11, 2023. To schedule a meeting with Aptose, investors can request a meeting on the online system here.